These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6614940)
1. [Studies on antibodies against rat and mouse tumors: its application to therapy]. Tsukada Y Gan To Kagaku Ryoho; 1983 Sep; 10(9):2069-76. PubMed ID: 6614940 [TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate]. Takahashi T; Seto M; Hara T Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010 [TBL] [Abstract][Full Text] [Related]
3. Application of monoclonal antibodies to tumor diagnosis and therapy. Rosen ST; Winter JN; Epstein AL Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro production and detection of monoclonal antibodies to surface components on metastatic variants of murine tumor cells. Miner KM; Reading CL; Nicolson GL Invasion Metastasis; 1981; 1(3):158-74. PubMed ID: 6897920 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells. Kirch ME; Hammerling U J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849 [TBL] [Abstract][Full Text] [Related]
7. The role of antibody in tumor immunity. Economou JS Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of the in vitro cytotoxicity of chlorambucil by monoclonal antibodies. Smyth MJ; Pietersz GA; McKenzie IF J Immunol; 1986 Nov; 137(10):3361-6. PubMed ID: 3772105 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin beta. Yu N; Xu W; Jiang Z; Cao Q; Chu Y; Xiong S Immunol Lett; 2007 Dec; 114(2):94-102. PubMed ID: 17964664 [TBL] [Abstract][Full Text] [Related]
10. LAMA tumor in the rat as an experimental model for pre-B-cell leukemia. De Jonge MW; De Leij L; Mesander G; Deenen GJ; Opstelten D; Kroese FG; van Imhoff GW; Nieuwenhuis P; The TH Cancer Res; 1989 Oct; 49(20):5682-8. PubMed ID: 2676147 [TBL] [Abstract][Full Text] [Related]
11. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with bispecific antibodies. Thielemans KM Verh K Acad Geneeskd Belg; 1995; 57(3):229-47; discussion 247-8. PubMed ID: 7483816 [TBL] [Abstract][Full Text] [Related]
13. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140 [TBL] [Abstract][Full Text] [Related]
14. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098 [TBL] [Abstract][Full Text] [Related]
15. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050 [TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies against human brain tumors]. Yoshida J Gan To Kagaku Ryoho; 1983 Jul; 10(7):1706-14. PubMed ID: 6347088 [TBL] [Abstract][Full Text] [Related]
17. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation. Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763 [TBL] [Abstract][Full Text] [Related]
18. Cocktails of human anti-cancer antibodies show a synergistic effect in nude mouse tumor xenografts. Glassy MC; McKnight ME; Kotlan B; Glassy EF; Koda K Hum Antibodies; 2007; 16(3-4):87-98. PubMed ID: 18334744 [TBL] [Abstract][Full Text] [Related]
19. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
20. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]